Hektoen provides a full suite of grant administration services for investigators conducting research in a variety of areas, including HIV treatment and prevention, behavioral health, oncology, healthcare associated infections, medical informatics, and more. With Hektoen’s administrative backing, our investigators have secured funding from the National Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Patient-Centered Outcomes Research Institute (PCORI), and countless other public and private funders to advance basic science, translational, and applied clinical research.

Here are just a few of the investigators who rely on Hektoen’s services to support their grant-funded research:

Mardge Cohen, MD

Dr. Cohen has been involved in caring for women with HIV since 1987. For over 25 years, she has seen the effects of smoking, abuse, posttraumatic stress (PTSD), and poor antiretroviral adherence on morbidity and mortality, including cancer, of women with HIV. She initiated and directed one of the first multi-disciplinary comprehensive HIV care programs for women, their partners, and children at Cook County Hospital with seed money from the Robert Wood Johnson Foundation and then continued this program with funding from HRSA from 1987-99. Since 1994, she has been the PI of the Chicago site of the NIH-funded Women’s Interagency HIV Study (WIHS), bringing together a motivated multidisciplinary array of scientists, clinicians and staff to address the current epidemic of HIV among women in the U.S. She also serves as Medical Director of Women Equity in Access to Care and Treatment – Rwanda, and leads an NIH grant to evaluate a youth-leader-conducted, trauma-informed cognitive behavior therapy intervention to improve adherence to antiretroviral therapy among youth in Kigali, Rwanda.

Sybil Hosek, PhD

Dr. Hosek’s 15 years of clinical experience working with youth living with HIV shape and inform her research efforts in the development and implementation of HIV-related research studies and bio-behavioral interventions. Her current research studies are largely focused on bio-behavioral prevention for youth, particularly pre-exposure prophylaxis (PrEP), and she is strongly invested in behavioral and biomedical intervention strategies that can halt the HIV epidemic among adolescents and young adults in the US as well as globally.

Leon Fogelfeld, MD

Dr. Fogelfeld is an endocrinologist with over 20 years of experience conducting clinical research trials to evaluate treatment of Type 2 Diabetes. Hektoen administers multiple pharmaceutical-funded grant programs in collaboration with Dr. Fogelfeld.

Other active Hektoen Principal Investigators include:

Oluwatoyin Adeyemi, MD
Mopelola Akintorin, MD
Araceli Andablo, MD
Sheila Badri, MD
Margo Bell, MD
Sean Bryant, MD
Denise Cunill, MD
Andrew Dennis, MD
Dipti Dighe, MD
Audrey French, MD
Marjorie Fujara, MD
Pamela Ganschow, MD
Marisol Gonzalez
Lisa M. Henry-Reid, MD
Courtney Hollowell, MD
Greg Huhn, MD
Susan Jans-Blumenfeld
Chester Kelly
Thomas Lad, MD
Ronald Lubelchek, MD
Elizabeth Marcus, MD
Benjamin Mba, MD
Arthur Moswin, MD

Shirin Muzaffar, MD
Tuan Nguyen, MD
Frances Norlock, DO
Temitope Oyedele, MD
Ashlesha Patel, MD
Urjeet Patel, MD
Kalyani Perumal, MD
Warren Piette, MD
Payman Sattar, MD
Jeff Schaider, MD
Julie Schmidt, MD
David Schwartz, MD
Kyungran Shim, MD
Anshu Singh, MD
Heather Stanley-Christian, MD
Luis David Sumoza, MD
William Trick, MD
Pamela Vergara-Rodriguez, MD
Carole Warshaw, MD
Kathleen Weber, MS
Sharon Welbel, MD
Chad Zawitz, MD